Readystate Asset Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$806K Buy
10,300
+2,500
+32% +$202K 0.03% 434
2026
Q1
$676K Buy
+7,800
New +$747K 0.03% 521
2025
Q2
Sell
-60,700
Closed -$5.45M 808
2025
Q1
$5.45M Buy
60,700
+42,600
+235% +$3.81M 0.18% 91
2024
Q4
$1.45M Sell
18,100
-117,700
-87% -$10.2M 0.04% 356
2024
Q3
$12.2M Buy
135,800
+128,800
+1,840% +$10.8M 0.23% 184
2024
Q2
$551K Sell
7,000
-101,000
-94% -$8.28M 0.02% 491
2024
Q1
$9.41M Buy
108,000
+106,700
+8,208% +$9.11M 0.13% 203
2023
Q4
$107K Buy
+1,300
New +$99.1K ﹤0.01% 583
2023
Q2
Sell
-4,000
Closed -$322K 359
2023
Q1
$322K Buy
+4,000
New +$326K 0.03% 208

Other funds holding MDT

Readystate Asset Management's MDT Position: Q2 2026 in Review

Readystate Asset Management increased its Medtronic (MDT) stake by 84% in Q2 2026, buying an estimated $201K and bringing the position to 5,451 shares worth $426K. The position accounts for 0.01% of the portfolio, ranked #698.

Readystate Asset Management first reported a position in MDT in Q1 2026 and has held it in 2 quarters since. 2,134 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Readystate Asset Management held 5,451 shares of Medtronic worth $426K as of Q2 2026.
  • Readystate Asset Management bought 2,492 Medtronic shares in Q2 2026, an estimated $201K.
  • Medtronic made up 0.01% of Readystate Asset Management's portfolio in Q2 2026, its #698 holding.
  • Readystate Asset Management first reported a position in Medtronic in Q1 2026 and has held it in 2 quarters since.
  • 2,134 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Readystate Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.